Mopivabil

• Description :

  Mopivabil is the antagonist of angiotensin II receptor[1].

• UNSPSC :

  12352005

• Target :

  Angiotensin Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/mopivabil.html

• Purity :

  99.66

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  COC1=CC(CC)=CC=C1OC(C(C)(C)C)=O

• Molecular Formula :

  C14H20O3

• Molecular Weight :

  236.31

• References & Citations :

  [1]WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2988562-84-9]